Advertisement

Erythrocyte glucose-6-phosphate dehydrogenase activity and risk of gestational diabetes

  • Parvaneh Asadi
  • Mahmood Vessal
  • Marjan Khorsand
  • Mohammad Ali TakhshidEmail author
Research article
  • 2 Downloads

Abstract

Purpose

Glucose-6-phosphate dehydrogenase (G6PD) is the regulating enzyme in the pentose phosphate pathway. A link between the activity of G6PD and diabetes mellitus has previously been reported. The association of G6PD activity with the pathogenesis of gestational diabetes mellitus (GDM) has not yet been investigated. The aim of the present study was to investigate the association of erythrocyte G6PD activity with major characteristics of GDM.

Methods

This case-control study was conducted at Hafez Hospital, Shiraz University of Medical Sciences, Shiraz, Iran from March to November 2017. Eighty-four age-matched pregnant women including GDM (n = 33), impaired glucose tolerance (IGT; n = 7), and normal glucose tolerance (NGT; n = 44) subjects were enrolled in this study. The levels of erythrocyte G6PD activity, fasting plasma glucose (FPG), insulin, malondialdehyde (MDA), and ferric reducing power (FRAP) of serum were measured. The level of homeostasis model for the assessment of insulin resistance (HOMA-IR) was calculated. The data were analyzed using SPSS software. P < 0.05 was considered statistically significant.

Results

The values of FPG, insulin, HOMA-IR, G6PD activity, and FRAP were significantly higher in GDM patients compared to NGT subjects. G6PD activity was correlated with FPG ((r = 0.224; P = 0.041). Binary logistic regression analysis revealed independent association of body mass index >25.88 [OR = 3.23, 95% CI 1.071–9.75, P = 0.037], HOMA- IR >2.33 [OR = 7.15, 95% CI 2.26–22.56, P < 0.001], and G6PD activity>21.17 U/g Hb [OR = 4.63, 95% CI 1.49–14.38, P = 0.008] with an increased risk of GDM. No significant change was observed among serum MDA levels in the three groups.

Conclusion

The findings demonstrate that increased G6PD activity is positively associated with the risk of GDM.

Keywords

Glucose-6-phosphate dehydrogenase Gestational diabetes Insulin resistance Oxidative stress 

Notes

Acknowledgments

This research was financially supported by a research grant from Shiraz Azad University.

Compliance with ethical standards

Conflict of interest

None declared.

References

  1. 1.
    Coustan DR. Gestational diabetes mellitus. Clin Chem. 2013;59:1310–21.  https://doi.org/10.1373/clinchem.2013.203331.CrossRefPubMedGoogle Scholar
  2. 2.
    Farahvar S, Walfisch A, Sheiner E. Gestational diabetes risk factors and long-term consequences for both mother and offspring: a literature review. Expert Rev Endocrinol Metab. 2019;14:63–74.CrossRefGoogle Scholar
  3. 3.
    Wang YP, Zhou LS, Zhao YZ, Wang SW, Chen LL, Liu LX, et al. Regulation of G6PD acetylation by SIRT2 and KAT9 modulates NADPH homeostasis and cell survival during oxidative stress. EMBO J. 2014;33:1304–20.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Gomez-Manzo S, Marcial-Quino J, Vanoye-Carlo A, Serrano-Posada H, Ortega-Cuellar D, Gonzalez-Valdez A, et al. Glucose-6-phosphate dehydrogenase: update and analysis of new mutations around the world. Int J Mol Sci. 2016;17.  https://doi.org/10.3390/ijms17122069.CrossRefGoogle Scholar
  5. 5.
    Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group. Bull World Health Organ. 1989;67:601–11.Google Scholar
  6. 6.
    Wang J, Xiao Q-Z, Chen Y-M, Yi S, Liu D, Liu Y-H, et al. DNA hypermethylation and X chromosome inactivation are major determinants of phenotypic variation in women heterozygous for G6PD mutations. Blood Cell Mol Dis. 2014;53:241–5.CrossRefGoogle Scholar
  7. 7.
    Cappai G, Songini M, Doria A, Cavallerano J, Lorenzi M. Increased prevalence of proliferative retinopathy in patients with type 1 diabetes who are deficient in glucose-6-phosphate dehydrogenase. Diabetologia. 2011;54:1539–42.CrossRefGoogle Scholar
  8. 8.
    Khanam A, Akter Q, Karim F, Zannat M. Erythrocyte Glucose-6-phosphate dehydrogenase level in type 2 diabetes male. Mymensingh Med J: 2018;27:103–7.PubMedGoogle Scholar
  9. 9.
    Popovic J. Glucose-6-phosphate Dehydrogenase Deficiency and Pre-eclampsia: Possibility of Treatment. Iran J Med Sci. 2011;36:324.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Santana MS, Monteiro WM, Costa MR, Sampaio VS, Brito MA, Lacerda MV, et al. High frequency of diabetes and impaired fasting glucose in patients with glucose-6-phosphate dehydrogenase deficiency in the Western brazilian Amazon. Am J Trop Med Hyg. 2014;91:74–6.CrossRefGoogle Scholar
  11. 11.
    Lai YK, Lai NM, Lee SWH. Glucose-6-phosphate dehydrogenase deficiency and risk of diabetes: a systematic review and meta-analysis. Ann Hematol. 2017;96:839–45.CrossRefGoogle Scholar
  12. 12.
    Zhang Z, Liew CW, Handy DE, Zhang Y, Leopold JA, Hu J, et al. High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and beta-cell apoptosis. FASEB J. 2010;24:1497–505.  https://doi.org/10.1096/fj.09-136572.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Choukem SP, Sobngwi E, Garnier JP, Letellier S, Mauvais-Jarvis F, Calvo F, et al. Hyperglycaemia per se does not affect erythrocyte glucose-6-phosphate dehydrogenase activity in ketosis-prone diabetes. Diabetes Metab. 2015;41:326–30.  https://doi.org/10.1016/j.diabet.2014.07.002.CrossRefPubMedGoogle Scholar
  14. 14.
    Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci. 2018;19.  https://doi.org/10.3390/ijms19113342.CrossRefGoogle Scholar
  15. 15.
    Farrar D, Duley L, Dowswell T, Lawlor DA. Different strategies for diagnosing gestational diabetes to improve maternal and infant health. Cochrane Database Syst Rev. 2017;8:CD007122.  https://doi.org/10.1002/14651858.CD007122.pub4.CrossRefPubMedGoogle Scholar
  16. 16.
    Yang SJ, Kim TN, Baik SH, Kim TS, Lee KW, Nam M, et al. Insulin secretion and insulin resistance in Korean women with gestational diabetes mellitus and impaired glucose tolerance. Korean J Intern Med. 2013;28:306–13.  https://doi.org/10.3904/kjim.2013.28.3.306.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Sun IO, Ko YM, Kim EY, Park KS, Jung HS, Ko SH, et al. Clinical characteristics and outcomes in renal transplant recipients with renal cell carcinoma in the native kidney. Korean J Intern Med. 2013;28:347–51.  https://doi.org/10.3904/kjim.2013.28.3.347.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Takhshid MA, Haem Z, Aboualizadeh F. The association of circulating adiponectin and + 45 T/G polymorphism of adiponectin gene with gestational diabetes mellitus in Iranian population. J Diabetes Metab Disord. 2015;14:30.  https://doi.org/10.1186/s40200-015-0156-z.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Takhshid MA, Zare Z. Resistin - 420 C/G polymorphism and serum resistin level in Iranian patients with gestational diabetes mellitus. J Diabetes Metab Disord. 2015;14:37.  https://doi.org/10.1186/s40200-015-0165-y.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Li J, Leng J, Li W, Zhang C, Feng L, Wang P, et al. Roles of insulin resistance and beta cell dysfunction in macrosomia among Chinese women with gestational diabetes mellitus. Prim Care Diabetes. 2018;12:565–73.  https://doi.org/10.1016/j.pcd.2018.07.010.CrossRefPubMedGoogle Scholar
  21. 21.
    Tai MM. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care. 1994;17:152–4.CrossRefGoogle Scholar
  22. 22.
    Bhutia Y, Ghosh A, Sherpa ML, Pal R, Mohanta PK. Serum malondialdehyde level: surrogate stress marker in the Sikkimese diabetics. J Nat Sci Biol Med. 2011;2:107–12.  https://doi.org/10.4103/0976-9668.82309.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Zhao H, Fan W, Dong J, Lu J, Chen J, Shan L, et al. Evaluation of antioxidant activities and total phenolic contents of typical malting barley varieties. Food Chem. 2008;107:296–304.CrossRefGoogle Scholar
  24. 24.
    Habibzadeh F, Habibzadeh P, Yadollahie M. On determining the most appropriate test cut-off value: the case of tests with continuous results. Biochem Med (Zagreb). 2016;26:297–307.  https://doi.org/10.11613/BM.2016.034.CrossRefGoogle Scholar
  25. 25.
    Takhshid MA, Zahediannejad Z, Aboualizadeh F, Moezzi L, Ranjbaran R. G22A polymorphism of adenosine Deaminase and its association with biochemical characteristics of gestational diabetes mellitus in an Iranian population. Iran J Med Sci. 2015;40:170–4.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Mule NK, Singh JN. Diabetes mellitus to neurodegenerative disorders: is oxidative stress fueling the flame? CNS Neurol Disord Drug Targets. 2018;17:644–53.  https://doi.org/10.2174/1871527317666180809092359.CrossRefPubMedGoogle Scholar
  27. 27.
    Araujo JR, Ramalho C, Correia-Branco A, Faria A, Ferraz T, Keating E, et al. A parallel increase in placental oxidative stress and antioxidant defenses occurs in pre-gestational type 1 but not gestational diabetes. Placenta. 2013;34:1095–8.  https://doi.org/10.1016/j.placenta.2013.09.001.CrossRefPubMedGoogle Scholar
  28. 28.
    Hajifaraji M, Jahanjou F, Abbasalizadeh F, Aghamohammadzadeh N, Abbasi MM, Dolatkhah N. Effect of probiotic supplements in women with gestational diabetes mellitus on inflammation and oxidative stress biomarkers: a randomized clinical trial. Asia Pac J Clin Nutr. 2018;27:581–91.  https://doi.org/10.6133/apjcn.082017.03.CrossRefPubMedGoogle Scholar
  29. 29.
    Jamilian M, Hashemi Dizaji S, Bahmani F, Taghizadeh M, Memarzadeh MR, Karamali M, et al. A randomized controlled clinical trial investigating the effects of Omega-3 fatty acids and vitamin E co-supplementation on biomarkers of oxidative stress, inflammation and pregnancy outcomes in gestational diabetes. Can J Diabetes. 2017;41:143–9.  https://doi.org/10.1016/j.jcjd.2016.09.004.CrossRefPubMedGoogle Scholar
  30. 30.
    Arribas L, Almansa I, Miranda M, Muriach M, Romero FJ, Villar VM. Serum malondialdehyde concentration and glutathione peroxidase activity in a longitudinal study of gestational diabetes. PLoS One. 2016;11:e0155353.  https://doi.org/10.1371/journal.pone.0155353.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Fabbrini E, Serafini M, Baric IC, Hazen SL, Klein S. Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects. Diabetes. 2014;63:976–81.CrossRefGoogle Scholar
  32. 32.
    Zamani-Ahari U, Zamani-Ahari S, Fardi-Azar Z, Falsafi P, Ghanizadeh M. Comparison of total antioxidant capacity of saliva in women with gestational diabetes mellitus and non-diabetic pregnant women. J Clin Exp Dent. 2017;9:e1282.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Surdacka A, Ciężka E, Pioruńska-Stolzmann M, Wender-Ożegowska E, Korybalska K, Kawka E, et al. Relation of salivary antioxidant status and cytokine levels to clinical parameters of oral health in pregnant women with diabetes. Arch Oral Biol. 2011;56:428–36.CrossRefGoogle Scholar
  34. 34.
    Gungor ES, Danisman N, Mollamahmutoglu L. Relationship between serum uric acid, creatinine, albumin and gestational diabetes mellitus. Clin Chem Lab Med. 2006;44:974–7.  https://doi.org/10.1515/CCLM.2006.173.CrossRefPubMedGoogle Scholar
  35. 35.
    Laughon SK, Catov J, Roberts JM. Uric acid concentrations are associated with insulin resistance and birthweight in normotensive pregnant women. Am J Obstet Gynecol. 2009;201:582 e1–6.  https://doi.org/10.1016/j.ajog.2009.06.043.CrossRefGoogle Scholar
  36. 36.
    Al-Rawi NH. Oxidative stress, antioxidant status and lipid profile in the saliva of type 2 diabetics. Diab Vasc Dis Res. 2011;8:22–8.  https://doi.org/10.1177/1479164110390243.CrossRefPubMedGoogle Scholar
  37. 37.
    Carette C, Dubois-Laforgue D, Gautier JF, Timsit J. Diabetes mellitus and glucose-6-phosphate dehydrogenase deficiency: from one crisis to another. Diabetes Metab. 2011;37:79–82.  https://doi.org/10.1016/j.diabet.2010.09.004.CrossRefPubMedGoogle Scholar
  38. 38.
    Park J, Rho HK, Kim KH, Choe SS, Lee YS, Kim JB. Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity. Mol Cell Biol. 2005;25:5146–57.  https://doi.org/10.1128/MCB.25.12.5146-5157.2005.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Minucci A, Giardina B, Zuppi C, Capoluongo E. Glucose-6-phosphate dehydrogenase laboratory assay: how, when, and why? IUBMB Life. 2009;61:27–34.  https://doi.org/10.1002/iub.137.CrossRefPubMedGoogle Scholar
  40. 40.
    Dessi S, Batetta B, Spano O, Pulisci D, Mulas MF, Muntoni S, et al. Serum lipoprotein pattern as modified in G6PD-deficient children during haemolytic anaemia induced by fava bean ingestion. Int J Exp Pathol. 1992;73:157–60.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Dessi S, Chiodino C, Batetta B, Fadda AM, Anchisi C, Pani P. Hepatic glucose-6-phosphate dehydrogenase, cholesterogenesis, and serum lipoproteins in liver regeneration after partial hepatectomy. Exp Mol Pathol. 1986;44:169–76.  https://doi.org/10.1016/0014-4800(86)90067-5.CrossRefPubMedGoogle Scholar
  42. 42.
    Park J, Choe SS, Choi AH, Kim KH, Yoon MJ, Suganami T, et al. Increase in glucose-6-phosphate dehydrogenase in adipocytes stimulates oxidative stress and inflammatory signals. Diabetes. 2006;55:2939–49.  https://doi.org/10.2337/db05-1570.CrossRefPubMedGoogle Scholar
  43. 43.
    Torloni M, Betran A, Horta B, Nakamura M, Atallah A, Moron A, et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev. 2009;10:194–203.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Molecular Biology-BiochemistryIslamic Azad UniversityShirazIran
  2. 2.Diagnostic Laboratory Sciences and Technology Research Center, Faculty of Paramedical SciencesShiraz University of Medical SciencesShirazIran

Personalised recommendations